tiprankstipranks
Trending News
More News >
Nascent Biotech (NBIO)
:NBIO
US Market

Nascent Biotech (NBIO) Income Statement

Compare
42 Followers

Nascent Biotech Income Statement

Last quarter (Q1 2025), Nascent Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Nascent Biotech's net income was $-377.39K. See Nascent Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 750.00K$ 0.00
Gross Profit
$ -319.51K$ 0.00$ 1.00M$ 750.00K$ 0.00
Operating Expenses
$ 2.23M$ 2.14M$ 1.46M$ 2.15M$ 3.45M
Depreciation and Amortization
$ 2.23M$ 2.16M$ 457.05K$ 1.40M$ 3.45M
EBITDA
$ 527.43K$ 0.00$ -134.41K$ 0.00$ -470.21K
Operating Income
$ -2.23M$ -2.16M$ -457.05K$ -1.40M$ -3.45M
Other Income/Expenses
$ 142.20K$ -645.21K$ -13.34K$ 441.60K$ -556.84K
Pretax Income
$ -2.09M$ -2.80M$ -470.39K$ -958.77K$ -4.00M
Net Income
$ -2.09M$ -2.80M$ -147.71K$ -1.31M$ -4.09M
Per Share Metrics
Basic EPS
$ -0.01$ -0.02$ 0.00$ -0.02$ -0.12
Diluted EPS
$ -0.01$ -0.02$ 0.00$ -0.02$ -0.12
Weighted Average Shares Outstanding
155.75M 118.57M 107.74M 72.34M 34.39M
Weighted Average Shares Outstanding (Diluted)
155.74M 118.57M 107.74M 72.34M 34.39M
Currency in USD

Nascent Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis